Daily Stocks News » TGT

Major Movers on May 22; ZLC, NTAP, TGT, TOL, SKS

Warren Paige — Wed, 22 May 2013 18:11:40 +0000

Shares of Zale Corp. (ZLC) catapulted more than 20% by afternoon trade after the jewelry retailer reported on Wednesday that it swung into fiscal third quarter profit. The Company also announced that the appointment of its new Chairman, Terry Burman, who previously served at the Chief Executive at rival firm, Signet Jewelers Ltd. For the [...]

Target Shares Gain on December Sales Results (TGT)

Warren Paige — Thu, 03 Jan 2013 21:07:38 +0000

Shares of Target Corporation (NYSE: TGT), the Minneapolis, Minnesota-based retailer, rose sharply in trading on Thursday after the company reported its sales results for the month of December.

For the five-week period ended December 29, 2012, Target reported net sales of $10,214 million, up from $10,138 million reported for the five-week period ended December [...]

Target’s Q3 Earnings Beat Estimates (TGT, WMT)

Warren Paige — Thu, 15 Nov 2012 16:00:49 +0000

United States’ second largest retail chain, Target Corp (NYSE: TGT) reported better-than-expected fiscal third-quarter results on Thursday. The company’s profit benefited from sale its consumer credit-card business. Meanwhile wider array of food products and discounts for cardholders brought more shoppers to TGT’s doorstep, boosting sales.

The company also upwardly revised its guidance on fiscal [...]

Pier 1 Imports Q2 Earnings Rise (PIR)

Warren Paige — Fri, 14 Sep 2012 09:14:29 +0000

Pier 1 Imports (NYSE: PIR) reported on Thursday that its fiscal second-quarter earnings climbed 58% as decorative home furnishings and gifts retailer’s sales soared even as it received income tax benefit.

The company also upwardly revised its lower and upper range of full-year earnings outlook to $1.08-$1.14 from previous estimate of $1.10-$1.16 a share.

[...]

Major Gainers and Losers on August 30; SRPT, CIEN, SHLD, VC, TGT, FB

Warren Paige — Thu, 30 Aug 2012 21:30:26 +0000

Shares of Sarepta Therapeutics Inc. (NASDAQ: SRPT), a biopharmaceutical company focused on rapidly advancing the development of its disease-modifying Duchenne muscular dystrophy drug candidates, surged in trading today.

SRPT shares ended the day 14.29% higher at $14.40 on above average volume of 4.99 million. The stock touched a 52-week high of $15.18 in trading [...]

Target Posts Strong Earnings as Same-store-Sales Climb, Full-Year Outlook Raised (TGT)

Warren Paige — Thu, 16 Aug 2012 08:28:15 +0000

Despite sluggish consumer spending, uncertain economy, discount retailer and general merchandiser, Target Corporation, (NYSE: TGT) reported better-than-expected fiscal second quarter results thanks to rising sales due to expansion of food sections. The company has also lifted its full-year outlook.

For the quarter, the company’s earnings stood at $1.06 per share, a climb if 3.4% [...]